Live Breaking News & Updates on Egalet Corporation Zyla

Stay updated with breaking news from Egalet corporation zyla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Acura Pharmaceuticals : Termination of Material Agreement

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to.
-Today at 11:24 am- MarketScreener ....

United States , New York , Petera Clemens , Commission File Number , Abuse Deterrent Pharma , Exchange Commission , Securities Exchange , Name Of Each Exchange On Which , Pfizer Inc , Zyla Life Sciences , Development Inc , Limitx Technology , Egalet Corporation Zyla , N North Court , Growth Company , Pharmaceuticals Inc , Acura Pharmaceuticals Inc , King Pharmaceuticals Research , Exact Name , Each Exchange , Securities Act , Exchange Act , Securities Exchange Act , Emerging Growth Company , Material Definitive , Egalet Corporation ,